Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis

@article{Kalil2013TreatmentOH,
  title={Treatment of hospital-acquired pneumonia with linezolid or vancomycin: a systematic review and meta-analysis},
  author={A. Kalil and M. Klompas and G. Haynatzki and M. Rupp},
  journal={BMJ Open},
  year={2013},
  volume={3}
}
  • A. Kalil, M. Klompas, +1 author M. Rupp
  • Published 2013
  • Medicine
  • BMJ Open
  • Objective Hospital-acquired pneumonia remains the most lethal and expensive nosocomial infection worldwide. Optimal therapy remains controversial. We aimed to compare mortality and clinical response outcomes in patients treated with either linezolid or vancomycin. Design Systematic review and meta-analysis. Data sources PubMed, EMBASE, Cochrane Library, American College of Physicians Journal Club, Evidence-based Medicine BMJ and abstracts from infectious diseases and critical care meetings were… CONTINUE READING
    61 Citations
    Linezolid versus vancomycin cost in the treatment of staphylococcal pneumonia.
    Treatment of community-acquired pneumonia
    • 1
    New guidelines for nosocomial pneumonia
    • 11

    References

    SHOWING 1-10 OF 40 REFERENCES
    Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
    • 431
    • PDF
    Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer.
    • 148
    • PDF
    Linezolid (PNU-100766) versus vancomycin in the treatment of hospitalized patients with nosocomial pneumonia: a randomized, double-blind, multicenter study.
    • 447
    • PDF
    Linezolid for the treatment of infections caused by Gram-positive pathogens in China.
    • 41
    Linezolid versus vancomycin for treatment of resistant Gram-positive infections in children
    • 146